🔗 Permalink

Inventor profile of:

Xichen Lin

City:

Shanghai

Country:

China

Published Applications:

Last publication date:

2026-02-26

Top Assignees for applications by Xichen Lin

The entities that hold a legal rights for patent applications filed by inventor Lin Xichen:

Gasherbrum Bio, Inc. 8 South San Francisco, CA United States
GlaxoSmithKline Intellectual Property Development Limited 5 Brentford, Middlesex, United Kingdom
GLAXO GROUP LIMITED 3 Greenford, Middlesex, United Kingdom
GlaxoSmithKline Intellectual Property Development Limited 2 Middlesex, United Kingdom
Glaxo Group Limited 1 Brentford, Middlesex, United Kingdom
Glaxo Group Limited 1 , United Kingdom
Glaxo Group Limited 1 Middlesex, United Kingdom
Glaxo Group Limited 1 Greenford, United Kingdom
Glaxo Wellcome House 1 Greenford, United Kingdom
Glaxo Wellcome House 1 Greenford, Middlesex, United Kingdom
Lhotse Bio, Inc 1 South San Francisco, CA United States
Glaxo Group Limited 1 Greenfield, Middlesex, United Kingdom
Glaxosmithline Intellectual Property Development Limited 1 Brentford, Middlesex, United Kingdom

Recent patent applications by Lin Xichen

Xichen Lin from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260055069A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#2 | 2025-08-07

US20250250269A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#3 | 2025-07-03

US20250214999A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#4 | 2025-06-26

US20250206757A1

Chemistry; metallurgy

5,8-DIHYDRO-1,7-NAPHTHYRIDINE DERIVATIVES AS GLP-1 AGONISTS FOR THE TREATMENT OF DIABETES

#5 | 2025-06-12

US20250188103A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#6 | 2025-04-10

US20250115606A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#7 | 2024-11-14

US20240376061A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#8 | 2024-11-07

US20240366639A1

Human necessities

HETEROCYCLIC GLP-1 AGONISTS

#9 | 2024-07-25

US20240246962A1

Chemistry; metallurgy

Heterocyclic GLP-1 agonists

#10 | 2024-03-14

US20240083886A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#11 | 2024-01-18

US20240018102A1

Chemistry; metallurgy

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY

#12 | 2023-12-07

US20230391760A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#13 | 2023-10-19

US20230331732A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#14 | 2023-10-12

US20230322771A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#15 | 2023-09-21

US20230295154A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#16 | 2023-06-22

US20230192633A1

Chemistry; metallurgy

Heterocyclic GLP-1 agonists

#17 | 2023-06-08

US20230174565A1

Chemistry; metallurgy

Heterocyclic GLP-1 agonists

#18 | 2023-06-01

US20230165846A1

Human necessities

HETEROCYCLIC GLP-1 AGONISTS

#19 | 2023-04-06

US20230107793A1

Chemistry; metallurgy

Heterocyclic GLP-1 agonists

#20 | 2023-03-09

US20230071840A1

Chemistry; metallurgy

HETEROCYCLIC GLP-1 AGONISTS

#21 | 2022-07-07

US20220213130A1

Chemistry; metallurgy

Heterocyclic GLP-1 agonists

#22 | 2019-01-10

US20190010135A1

Chemistry; metallurgy

1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

#23 | 2017-07-13

US20170197978A1

Chemistry; metallurgy

Heteroaryl substituted compounds as RORγ inhibitors

#24 | 2017-07-06

US20170190681A1

Chemistry; metallurgy

1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

#25 | 2017-05-04

US20170121313A1

Chemistry; metallurgy

Compounds

#26 | 2017-04-13

US20170101399A1

Chemistry; metallurgy

Compounds

#27 | 2015-10-22

US20150299121A1

Chemistry; metallurgy

Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases

#28 | 2013-01-10

US20130012491A1

Chemistry; metallurgy

PYRIMIDINE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

#29 | 2012-11-08

US20120283297A1

Chemistry; metallurgy

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

#30 | 2012-04-26

US20120101136A1

Human necessities

5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1- PHOSPHATE RECEPTOR AGONISTS

#31 | 2012-04-26

US20120101134A1

Chemistry; metallurgy

5-MEMBERED HETEROARYL DERIVATIVES USED AS SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONISTS

#32 | 2012-04-26

US20120101124A1

Chemistry; metallurgy

1,2,4-OXADIAZOL DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS SPHINGOSINE 1-PHOSPHATE 1 RECEPTOR AGONISTS

#33 | 2012-04-26

US20120101123A1

Chemistry; metallurgy

COMPOUNDS

#34 | 2012-04-19

US20120094979A1

Chemistry; metallurgy

THIAZOLE OR THIADIZALOE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

#35 | 2011-11-03

US20110269738A1

Chemistry; metallurgy

Heterocyclic compounds

#36 | 2011-04-14

US20110086839A1

Chemistry; metallurgy

1,2,4-oxadiazole indole compounds

#37 | 2010-02-04

US20100029729A1

Chemistry; metallurgy

COMPOUNDS

#38 | 2010-01-14

US20100010053A1

Chemistry; metallurgy

COMPOUNDS

InventorID:

29856 ⎘